Clinical predictors of NT-proBNP response to early initiation of sacubitril/valsartan after hospitalisation for decompensated heart failure: An analysis of the TRANSITION study

Back

ESC Premium Access

Clinical predictors of NT-proBNP response to early initiation of sacubitril/valsartan after hospitalisation for decompensated heart failure: An analysis of the TRANSITION study

Session: New treatment studies in heart failure

Topic: Pharmacotherapy

Speaker: Professor D. Pascual Figal (Murcia, ES)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Professor Domingo Pascual Figal

Virgen de la Arrixaca University Clinical Hospital, Murcia (Spain)

5 presentations

1 follower

8 more presentations in this session

Sequential nephron blockade with diuretics improves diastolic dysfunction in patients with resistant hypertension, a substudy a the PHARES trial

Speaker: Doctor D. Fouassier (Paris, FR)

Inhaled iloprost, exercise hemodynamics, and ventricular performance in heart failure with preserved ejection fraction

Speaker: Doctor J. Cheng (Taipei, TW)

Drug effect of luseogliflozin and voglibose on heart failure with preserved ejection fraction in diabetic patients: a multicenter randomized-controlled trial

Speaker: Doctor H. Kihara (Asahikawa, JP)

Diuretic and renal effects of spironolactone and heart failure hospitalizations: A TOPCAT Americas analysis

Speaker: Associate Professor A. Kalogeropoulos (Stony Brook, US)

Access

Use of phenomapping to determine response of treatment by sacubitril/valsartan in patients with heart failure with reduced ejection fraction

Speaker: Mr M. Godet (Rouen, FR)

Access the full session

New treatment studies in heart failure

Speakers: Professor D. Pascual Figal, Doctor D. Fouassier, Doctor J. Cheng, Doctor H. Kihara, Associate Professor A. Kalogeropoulos...

Access

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources